Back to search

Article

A benchmark of DNA methylation deconvolution methods for tumoral fraction estimation using DecoNFlow

2025-11-27

Abstract excerpt

In cancer patients, circulating cell-free DNA (cfDNA) is released into body fluids from both healthy and cancer cells. The proportion of tumor-derived cfDNA serves as a surrogate marker of tumor burden allowing disease monitoring. Tumoral cfDNA can be distinguished based on patient specific tumoral mutations or using more general tumor specific DNA methylation patterns, that are preserved on tumoral cfDNA. DNAm pr...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b9edab66-abf7-590f-9bcd-b4835a04d73f
DOI
10.1101/2025.11.27.688590
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A benchmark of DNA methylation deconvolution methods for tumoral fraction estimation using DecoNFlowDOI 10.1101/2025.11.27.688590
Select a neighboring publication to make it the new centre.